Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

242 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The impact of concurrent granulocyte-macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial.
Hoffman KE, Pugh SL, James JL, Scarantino C, Movsas B, Valicenti RK, Fortin A, Pollock J, Kim H, Brachman DG, Berk LB, Bruner DW, Kachnic LA. Hoffman KE, et al. Qual Life Res. 2014 Aug;23(6):1841-58. doi: 10.1007/s11136-014-0628-5. Epub 2014 Feb 4. Qual Life Res. 2014. PMID: 24492945 Free PMC article. Clinical Trial.
Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional control.
Albert JM, Buzdar AU, Guzman R, Allen PK, Strom EA, Perkins GH, Woodward WA, Hoffman KE, Tereffe W, Hunt KK, Buchholz TA, Oh JL. Albert JM, et al. Among authors: hoffman ke. Breast Cancer Res Treat. 2011 Jul;128(2):421-7. doi: 10.1007/s10549-011-1562-7. Epub 2011 May 8. Breast Cancer Res Treat. 2011. PMID: 21553292 Clinical Trial.
Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial.
Pinnix C, Perkins GH, Strom EA, Tereffe W, Woodward W, Oh JL, Arriaga L, Munsell MF, Kelly P, Hoffman KE, Smith BD, Buchholz TA, Yu TK. Pinnix C, et al. Among authors: hoffman ke. Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1089-94. doi: 10.1016/j.ijrobp.2011.09.021. Epub 2011 Dec 14. Int J Radiat Oncol Biol Phys. 2012. PMID: 22172912 Free PMC article. Clinical Trial.
Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer.
Pugh TJ, Munsell MF, Choi S, Nguyen QN, Mathai B, Zhu XR, Sahoo N, Gillin M, Johnson JL, Amos RA, Dong L, Mahmood U, Kuban DA, Frank SJ, Hoffman KE, McGuire SE, Lee AK. Pugh TJ, et al. Among authors: hoffman ke. Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):946-53. doi: 10.1016/j.ijrobp.2013.08.032. Epub 2013 Oct 15. Int J Radiat Oncol Biol Phys. 2013. PMID: 24139077 Free PMC article.
Impact of Adherence to Quality Measures for Localized Prostate Cancer on Patient-reported Health-related Quality of Life Outcomes, Patient Satisfaction, and Treatment-related Complications.
Sohn W, Resnick MJ, Greenfield S, Kaplan SH, Phillips S, Koyama T, Goodman M, Hamilton AS, Hashibe M, Hoffman KE, Paddock LE, Stroup AM, Wu XC, Penson DF, Barocas DA. Sohn W, et al. Among authors: hoffman ke. Med Care. 2016 Aug;54(8):738-44. doi: 10.1097/MLR.0000000000000562. Med Care. 2016. PMID: 27219634 Free PMC article.
Patient-reported Urinary, Bowel, and Sexual Function After Hypofractionated Intensity-modulated Radiation Therapy for Prostate Cancer: Results From a Randomized Trial.
Hoffman KE, Skinner H, Pugh TJ, Voong KR, Levy LB, Choi S, Frank SJ, Lee AK, Mahmood U, McGuire SE, Schlembach PJ, Du W, Johnson J, Kudchadker RJ, Kuban DA. Hoffman KE, et al. Am J Clin Oncol. 2018 Jun;41(6):558-567. doi: 10.1097/COC.0000000000000325. Am J Clin Oncol. 2018. PMID: 27635624
Prospective Phase 2 Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes.
Frank SJ, Pugh TJ, Blanchard P, Mahmood U, Graber WJ, Kudchadker RJ, Davis JW, Kim J, Choi H, Troncoso P, Kuban DA, Choi S, McGuire S, Hoffman KE, Chen HC, Wang X, Swanson DA. Frank SJ, et al. Among authors: hoffman ke. Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):374-382. doi: 10.1016/j.ijrobp.2017.09.050. Epub 2017 Oct 12. Int J Radiat Oncol Biol Phys. 2018. PMID: 29229325 Free article. Clinical Trial.
Validation of Patient-Reported Outcomes in Patients With Nonmetastatic Breast Cancer Receiving Comprehensive Nodal Irradiation in the RadComp Trial.
Hahn EA, Pugh SL, Lu HL, Vela AM, Gillespie EF, Nichols EM, Wright JL, MacDonald SM, Cahlon O, Baas C, Braunstein LZ, Fang LC, Freedman GM, Jimenez RB, Kesslering CM, Mishra MV, Mutter RW, Ohri N, Rosen LR, Urbanic JJ, Jagsi R, Mitchell SA, Bekelman JE, Cella D; Study Group Investigators:. Hahn EA, et al. Int J Radiat Oncol Biol Phys. 2024 Sep 1;120(1):149-161. doi: 10.1016/j.ijrobp.2024.03.020. Epub 2024 May 13. Int J Radiat Oncol Biol Phys. 2024. PMID: 38739047 Free PMC article. Clinical Trial.
242 results